Featured in Genetic Engineering & Biotechnology News: Addimmune™ will continue 10+ years of #R&D by #AGT, working to potentially cure #HIV with #genetherapy. Read more here. bit.ly/3Q1XN7T

It was an honor to host Councilmember CM Marilyn Balcombe at our Rockville office! Thank you for sharing the many great projects you are working on for #MontgomeryCounty – #AGT looks forward to your continued support as we work to advance curative #genetherapy #technologies!

#Transplants experience a higher success rate when matched with people from the same #ethnic background. On National #MinorityDonorAwarenessDay, we emphasize the growing need for #minority donors – and encourage you to consider #OrganDonation.

Building on encouraging Phase I results, Addimmune™ is working towards launching a Phase II trial to establish its #HIV #genetherapy #treatment efficacy. Read on Precision Medicine Online. bit.ly/3QeLWDC

With more than 200,000 cases annually, #LungCancer remains one of the most common forms of #cancer in the United States. Read about #AGT’s plan to fight cancer here: bit.ly/3Qj38I0. #WorldLungCancerDay #SolidTumors

BREAKING: Addimmune™ to go public through a #business combination with @10XCapitalVC! Find out more here. bit.ly/3Otyycm

#GenBio Reports: Anticipating a Phase II Trial, Addimmune™ is currently surveying potential manufacturers and trial sites as the company waits on protocol approval from the FDA. Read more on Genetic Engineering & Biotechnology News. bit.ly/3P8h0Uo

A patient in Geneva has achieved #HIV remission following a stem #cell transplant, possibly making them the sixth example of an HIV #cure. Learn more here. hubs.li/Q0208c_W0

Featured in #BethesdaMagazine by @MoCo360Media: #AGT has been recognized as a Top Place to Work! We’re known to have the “happiest employees in the #Bethesda area, according to research by Best Companies Group.” Read here. bit.ly/44LVp8Z

A sixth patient has unexpectedly been cured of #HIV in #Geneva following a risky #stemcell transplant procedure, providing more evidence that extended viral suppression is possible. #Genetherapy could provide a safer, more reliable solution. Read more. hubs.li/Q02099pS0

Your #immune system has powerful built-in functions like “clonal expansion” that #scientists use to maximize the potency of #genetherapy. When T #cells divide in response to pathogens, they copy #gene therapies like #AGT103 in the process. Read more. hubs.li/Q0209fgc0

#Research is the cornerstone of progress. Innovative #cancer research is the key to improving patient outcomes. #WorldCancerResearch

Featured in @WBJOnline: #AGT welcomes Nick Tressler, MBA as Chief Financial Officer! Nick brings 20+ years of experience maximizing stakeholder value as a strategic financial exec & enterprise leader in the #lifesciences industry and beyond. bit.ly/3rizQiP

Did you know? Since AGT103-T is made using free-floating T #cells in the blood, a simple blood draw makes it possible to create AGT103-T outside the body. Learn more about the process here. hubs.li/Q0209l2v0

#AGT is a Top Place to Work! In the latest edition of #BethesdaMagazine by @MoCo360Media, American Gene has the “happiest employees in the #Bethesda area, according to research by Best Companies Group.” Read here. bit.ly/3RFHHBD

According to the United Nations, since the start of the epidemic around 84.2 million people have acquired #HIV and around 40.1 million people have died of #AIDS-related illnesses. Let’s continue to advocate for accessible care for #PLWHA to improve patient outcomes. #AIDSAwareness

#Addimmune is participating in the #WalktoEndHIV with @WhitmanWalker in #DC. Join us on October 21st to raise funds to support WWH’s mission of providing dependable, high-quality & accessible #healthcare to those living with or affected by #HIV/#AIDS. hubs.li/Q023Cyqk0

Featured in @BioBuzzMaryland: “Being located in Rockville provides advantages for #AGT, as the presence of laboratory suppliers, #research groups, and clinics create an ecosystem that facilitates projects like AGT’s efforts to functionally cure #HIV.” bit.ly/3ZzbOgb

We were excited to participate in the ROTH MKM Healthcare Opportunities Conference today, and share our vision for #genetherapy and its potential to impact human #health.

The Walk to End #HIV by @WhitmanWalker has been moved to Saturday, December 2nd in #DC. Aligning with #WorldAIDSday, we’ll be joining the community in fighting #stigma and promoting better patient outcomes for #PLWHA. We’re excited to see you there! hubs.li/Q025tryP0